about
Ginkgo biloba for intermittent claudicationSarpogrelate for peripheral arterial diseaseProstanoids for critical limb ischaemiaGinkgo biloba for intermittent claudicationPotential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefitsLow-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.Therapeutic angiogenesis for critical limb ischaemia.One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysisNovel screening metric for the identification of at-risk peripheral artery disease patients using administrative claims data.Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient dataThe acute effects of lower limb intermittent negative pressure on foot macro- and microcirculation in patients with peripheral arterial disease.Patterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy.Quantifying in vivo hemodynamic response to exercise in patients with intermittent claudication and abdominal aortic aneurysms using cine phase-contrast MRIOptimal management of infrainguinal arterial occlusive diseaseStatin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryIn vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia.The association of visceral adiposity with cardiovascular events in patients with peripheral artery disease.A biomarker panel for peripheral arterial disease.Potential explanatory factors for higher incident hip fracture risk in older diabetic adults.Biomarkers of peripheral arterial disease.Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease.Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.Optimal management of peripheral arterial disease for the non-specialistReduction in ischemic brain injury following the administration of pentoxifylline after transient global ischemia/ reperfusion in a rat modelMicro- and Nanoparticles for Treating Cardiovascular Disease.A Meta-Analysis of Randomized Controlled Trials on Antiplatelet Agents Versus Placebo/Control for Treating Peripheral Artery Disease.Age, male gender, and atrial fibrillation predict lower extremity amputation or revascularization in patients with peripheral artery diseases: a population-based investigation.Surgical infrainguinal revascularization for peripheral arterial disease: factors affecting patency rateNovel method to assess arterial insufficiency in rodent hind limb.A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in FranceGene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.Management of peripheral arterial disease in the elderly: focus on cilostazolRole of image-guided vascular intervention in therapeutic angiogenesis translational research.Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004.Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.Therapeutic angiogenesis in critical limb ischemia.Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease.Ethnicity and peripheral artery disease.Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease
P2860
Q24202149-88491D49-1935-4E43-AAD7-112809BBF184Q24240316-FBC4FC02-544F-408E-8E5B-11B81238223FQ24240537-687F3364-C8A7-4451-80F8-E93D46B1CABFQ24241126-31982C32-B4D5-4931-8369-3F6E1A642944Q26998381-2448A929-1143-4D24-9450-8194A62F0BF6Q27694706-DFCD9B26-9546-4DEC-8084-D855DD34F716Q30430614-CFD47971-7D31-4109-8F6E-F9B8AB212AD0Q30456666-FAEA7008-AFA3-40EA-AB06-8DF38C147251Q30841242-3CB03014-1135-480E-A8C2-8E28E810B07FQ31028283-14A4D7B5-6BDE-4B6D-81A3-60CD049ED06EQ33416679-83E59925-5C2C-42AB-8320-1DAB5C9F3313Q33470642-822E8658-E4DB-42BD-BD1E-7F08E3DFFBF0Q33635120-AAFCECB8-0DDE-4F6D-B697-500E7C5B6E52Q34236317-C4A44887-B1DD-49FF-A8F0-ADA056275B75Q34434785-517216D5-B202-42CC-87A3-3DDFCB3FA6BFQ34436787-169CB773-41E0-47A6-8695-785F58324235Q34816608-7DD1A42A-22FE-4B61-8002-CEDAFEBB1F82Q35079997-49A39AB7-464D-4F17-93F0-0EFF4142D4B5Q35098249-60DF1868-23B9-40E0-87DA-A57632387F55Q35155119-ADF779A6-AEE0-4864-9D62-E2518663DC6DQ35170187-4141EE84-DCF8-45CE-A67E-BEDBAF12AAD3Q35232453-01D98B58-AEE2-411F-B030-AE36949D78DEQ35618768-0694B65D-497F-4EBC-BAFB-D7C82ECD9A1BQ35761784-5AA468D5-688B-4B8E-9814-0C4440438090Q35765300-BF6A5E7B-85E1-44FE-82F5-F257D6CCA35CQ35801354-46557BEC-F694-4653-9C1E-AFBD68A220E8Q36194774-A67E9A88-499A-4BF8-8FDE-0054CED4E2B9Q36238939-49821CF2-DCC0-4F5D-8E70-F889A282F4FEQ36469420-75D404D6-B78C-41BC-9D9F-AB49B83D38E0Q36558124-F4233AE8-E807-4A20-B822-26893E6F14AFQ36678307-AFC9BB7E-5FE6-4E57-8B4F-76D15910A596Q36725128-659663D8-5E4C-4FD7-9446-AE76CF75691DQ36892864-8045DFBF-19EE-4439-A9DE-8688C663B5D6Q36941842-A2944B87-988E-4B5E-8292-B5595CB16947Q37084956-CA136CC9-2DE5-4F3E-8879-AE5D7B4492A3Q37119681-35E68A13-50E8-4459-ACCE-68BBE8C40AC6Q37142832-D1FDE48C-D63A-4BF5-B4C9-50CD98FE3C96Q37197102-27759089-8775-4E20-9F9E-4981C0D993BFQ37307276-69E96830-E593-4AD8-83D9-042C11BAB230Q37327098-A29FB2F1-6A73-4FE4-A064-4CA318972251
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Medical treatment of peripheral arterial disease
@ast
Medical treatment of peripheral arterial disease
@en
Medical treatment of peripheral arterial disease
@nl
type
label
Medical treatment of peripheral arterial disease
@ast
Medical treatment of peripheral arterial disease
@en
Medical treatment of peripheral arterial disease
@nl
prefLabel
Medical treatment of peripheral arterial disease
@ast
Medical treatment of peripheral arterial disease
@en
Medical treatment of peripheral arterial disease
@nl
P356
P1476
Medical treatment of peripheral arterial disease
@en
P2093
Paul E Norman
P304
P356
10.1001/JAMA.295.5.547
P407
P577
2006-02-01T00:00:00Z